Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Biopharmaceutical Statistics
|
February 16, 2024
Considerations for master protocols using external controls
Jie Chen, Xiaoyun Nicole Li, Chengxing Cindy Lu, et al.
Therapeutic Innovation & Regulatory Science
|
May 3, 2022
Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker-Selected Populations in Oncology Confirmatory Trials
Weidong Zhang, Sunhee Ro, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
June 23, 2021
Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials
Chengxing Cindy Lu, Xiaoyun Nicole Li, Kristine Broglio, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
August 5, 2025
Ensuring Quality and Interpretability of Progression Free Survival and Overall Survival in Oncology Clinical Trials
Philip He, Haijun Ma, Chengxing Cindy Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical Considerations
Chengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Statistics in Biopharmaceutical Research
|
June 5, 2023
Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials
Rong Liu, Ying Yuan, Suman Sen, et al.
Therapeutic Innovation & Regulatory Science
|
August 19, 2025
Company Sponsored Platform Trials: Recommendations and Lessons Learned from Cross-Industry Interviews
Yujun Wu, Chengxing Cindy Lu, Mehreteab Aregay, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Biopharmaceutical Statistics
|
February 16, 2024
Considerations for master protocols using external controls
Jie Chen, Xiaoyun Nicole Li, Chengxing Cindy Lu, et al.
Therapeutic Innovation & Regulatory Science
|
May 3, 2022
Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker-Selected Populations in Oncology Confirmatory Trials
Weidong Zhang, Sunhee Ro, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
June 23, 2021
Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials
Chengxing Cindy Lu, Xiaoyun Nicole Li, Kristine Broglio, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
August 5, 2025
Ensuring Quality and Interpretability of Progression Free Survival and Overall Survival in Oncology Clinical Trials
Philip He, Haijun Ma, Chengxing Cindy Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical Considerations
Chengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Statistics in Biopharmaceutical Research
|
June 5, 2023
Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials
Rong Liu, Ying Yuan, Suman Sen, et al.
Therapeutic Innovation & Regulatory Science
|
August 19, 2025
Company Sponsored Platform Trials: Recommendations and Lessons Learned from Cross-Industry Interviews
Yujun Wu, Chengxing Cindy Lu, Mehreteab Aregay, et al.
Page
of 1